v3.24.3
Interim Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 392 $ 767
Accounts receivable 51 81
Total current assets 443 848
Non- current assets    
Long term restricted deposit 11 11
Operating right of use asset 40 84
Property and equipment, net 39 56
Total non-current assets 90 151
Total assets 533 999
Current liabilities    
Trade and other payables 376 473
Non-current liabilities    
 Stockholders’ loans 155 161
Total liabilities 531 634
Contingent liabilities and commitments
Stockholders’ Equity    
Common Stock, par value $0.001 per share, 600,000,000 and 250,000,000 shares authorized as of September 30, 2024, and December 31, 2023, respectively. 70,783,144 and 69,931,056 shares issued as of September 30, 2024, and December 31, 2023, respectively. 70 69
Additional paid-in capital 16,392 15,135
Accumulated deficit (16,460) (14,839)
Total Stockholders’ equity 2 365
Total liabilities and stockholders’ equity $ 533 $ 999

Source